Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients.

GC Cell

Status: Completed

Conditions: Hepatocellular Carcinoma

Study type: Observational

Funder types: Industry

Identifiers

NCT01890291

IIC-I02

Details and patient eligibility

About

To observation that long term follow-up study of 'Immuncell-LC groups' and 'Non-treatment groups' in patient undergo curative resection (PEIT, RFA or Operation) for hepatocellular carcinoma in Korea

Enrollment: 162 patients

Sex: All

Ages: 20 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Prior to the test, patient is fully explained about the purpose/ contents and characteristics of the testing medication, and the patient him(her)self, the guardian or the legal representative signed on written consent.
• Patients of participated in the(ClinicalTrials.gov Identifier:NCT00699816)clinical trial.

Exclusion criteria

• Patient who is incongruent to this clinical trial by sub-investigator's opinion.

Trial design

162 participants in 2 patient groups

Non-treatment Group

Description:

Patients who were in non-treatment group in phase 3 clinical trial IIC-I01(NCT00699816).

Immuncell-LC Group

Description:

Patients who were in Immuncell-LC group in phase 3 clinical trial IIC-I01(NCT00699816).